Gabapentin Market Report

Global Gabapentin Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jan 29, 2021
  • PAGES：235
  • REPORT CODE：GMM611395
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise. Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.

    The Gabapentin is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period. The research provides insights for the global Gabapentin market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Gabapentin industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Gabapentin Market Segmentations:

    By Players:

    • Marksans Pharma

    • Alkem

    • Jiangsu Hengrui

    • Sun Pharmaceutical

    • Sailike

    • Novartis

    • Mylan

    • Jiangsu Enhua

    • Arbor Pharma

    • Assertio Therapeutics

    • Apotex

    • Aurobindo Pharma

    • Glenmark

    • Intas

    • Amneal

    • TEVA

    By Types:

    • Capsule

    • Tablet

    By End-User:

    • Epilepsy

    • Neuropathic Pain

    • Restless Legs Syndrome

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gabapentin Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Gabapentin Market Size and Growth Rate of Capsule from 2014 to 2026

      • 1.3.2 Global Gabapentin Market Size and Growth Rate of Tablet from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Gabapentin Market Size and Growth Rate of Epilepsy from 2014 to 2026

      • 1.4.2 Global Gabapentin Market Size and Growth Rate of Neuropathic Pain from 2014 to 2026

      • 1.4.3 Global Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2014 to 2026

      • 1.4.4 Global Gabapentin Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Gabapentin Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Gabapentin Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Gabapentin Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gabapentin Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gabapentin by Major Types

      • 3.4.1 Gabapentin Market Size and Growth Rate of Capsule

      • 3.4.2 Gabapentin Market Size and Growth Rate of Tablet

    4 Segmentation of Gabapentin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gabapentin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gabapentin in Epilepsy

      • 4.4.2 Market Size and Growth Rate of Gabapentin in Neuropathic Pain

      • 4.4.3 Market Size and Growth Rate of Gabapentin in Restless Legs Syndrome

      • 4.4.4 Market Size and Growth Rate of Gabapentin in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Gabapentin Production Analysis by Major Regions

    • 5.2 Global Gabapentin Consumption Analysis by Major Regions

    • 5.3 Global Gabapentin Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Gabapentin Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Gabapentin Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Gabapentin Production, Import, Consumption and Export Analysis

    6 Product Commodity of Gabapentin Market in Major Countries

    • 6.1 Top 5 Export Countries in Gabapentin market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Gabapentin market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Gabapentin market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gabapentin market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Gabapentin market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Gabapentin market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Gabapentin Landscape Analysis

    • 7.1 North America Gabapentin Landscape Analysis by Major Types

    • 7.2 North America Gabapentin Landscape Analysis by Major End-Users

    • 7.3 North America Gabapentin Landscape Analysis by Major Countries

      • 7.3.1 United States Gabapentin Market Volume and Growth Rate

      • 7.3.2 Canada Gabapentin Market Volume and Growth Rate

      • 7.3.3 Mexico Gabapentin Market Volume and Growth Rate

    8 Europe Gabapentin Landscape Analysis

    • 8.1 Europe Gabapentin Landscape Analysis by Major Types

    • 8.2 Europe Gabapentin Landscape Analysis by Major End-Users

    • 8.3 Europe Gabapentin Landscape Analysis by Major Countries

      • 8.3.1 Germany Gabapentin Market Volume and Growth Rate

      • 8.3.2 UK Gabapentin Market Volume and Growth Rate

      • 8.3.3 France Gabapentin Market Volume and Growth Rate

      • 8.3.4 Italy Gabapentin Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Gabapentin Market Volume and Growth Rate

      • 8.3.6 Spain Gabapentin Market Volume and Growth Rate

      • 8.3.7 Belgium Gabapentin Market Volume and Growth Rate

      • 8.3.8 Poland Gabapentin Market Volume and Growth Rate

      • 8.3.9 Russia Gabapentin Market Volume and Growth Rate

      • 8.3.10 Turkey Gabapentin Market Volume and Growth Rate

    9 Asia Pacific Gabapentin Landscape Analysis

    • 9.1 Asia Pacific Gabapentin Landscape Analysis by Major Types

    • 9.2 Asia Pacific Gabapentin Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Gabapentin Landscape Analysis by Major Countries

      • 9.3.1 China Gabapentin Market Volume and Growth Rate

      • 9.3.2 Japan Gabapentin Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Gabapentin Market Volume and Growth Rate

      • 9.3.4 India Gabapentin Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Gabapentin Market Volume and Growth Rate

      • 9.3.6 South Korea Gabapentin Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Gabapentin Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Gabapentin Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Gabapentin Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Gabapentin Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Gabapentin Market Volume and Growth Rate

      • 10.3.2 Brazil Gabapentin Market Volume and Growth Rate

      • 10.3.3 Nigeria Gabapentin Market Volume and Growth Rate

      • 10.3.4 South Africa Gabapentin Market Volume and Growth Rate 

      • 10.3.5 Argentina Gabapentin Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Marksans Pharma

      • 11.1.1 Marksans Pharma Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Alkem

      • 11.2.1 Alkem Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Jiangsu Hengrui

      • 11.3.1 Jiangsu Hengrui Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sun Pharmaceutical

      • 11.4.1 Sun Pharmaceutical Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Sailike

      • 11.5.1 Sailike Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Novartis

      • 11.6.1 Novartis Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Mylan

      • 11.7.1 Mylan Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Jiangsu Enhua

      • 11.8.1 Jiangsu Enhua Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Arbor Pharma

      • 11.9.1 Arbor Pharma Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Assertio Therapeutics

      • 11.10.1 Assertio Therapeutics Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Apotex

      • 11.11.1 Apotex Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Aurobindo Pharma

      • 11.12.1 Aurobindo Pharma Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Glenmark

      • 11.13.1 Glenmark Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Intas

      • 11.14.1 Intas Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Amneal

      • 11.15.1 Amneal Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 TEVA

      • 11.16.1 TEVA Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 96 Figures and 199 Tables)

    • Figure Product Picture

    • Figure Gabapentin Market Size and Growth Rate of Capsule from 2014 to 2026

    • Figure Gabapentin Market Size and Growth Rate of Tablet from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Gabapentin Market Size and Growth Rate of Epilepsy from 2014 to 2026

    • Figure Global Gabapentin Market Size and Growth Rate of Neuropathic Pain from 2014 to 2026

    • Figure Global Gabapentin Market Size and Growth Rate of Restless Legs Syndrome from 2014 to 2026

    • Figure Global Gabapentin Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Gabapentin Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gabapentin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gabapentin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gabapentin by Different Types from 2014 to 2026

    • Table Consumption Share of Gabapentin by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Capsule

    • Figure Market Size and Growth Rate of Tablet

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gabapentin by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gabapentin by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Epilepsy

    • Figure Market Size and Growth Rate of Neuropathic Pain

    • Figure Market Size and Growth Rate of Restless Legs Syndrome

    • Figure Market Size and Growth Rate of Others

    • Table Global Gabapentin Production by Major Regions

    • Table Global Gabapentin Production Share by Major Regions

    • Figure Global Gabapentin Production Share by Major Regions in 2014

    • Figure Global Gabapentin Production Share by Major Regions in 2018

    • Figure Global Gabapentin Production Share by Major Regions in 2026

    • Table Global Gabapentin Consumption by Major Regions

    • Table Global Gabapentin Consumption Share by Major Regions

    • Figure Global Gabapentin Consumption Share by Major Regions in 2014

    • Figure Global Gabapentin Consumption Share by Major Regions in 2018

    • Figure Global Gabapentin Consumption Share by Major Regions in 2026

    • Table North America Gabapentin Production, Import, Consumption and Export Analysis

    • Table Europe Gabapentin Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Gabapentin Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Gabapentin Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gabapentin market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gabapentin market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gabapentin market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gabapentin market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Gabapentin Consumption by Types from 2014 to 2026

    • Table North America Gabapentin Consumption Share by Types from 2014 to 2026

    • Figure North America Gabapentin Consumption Share by Types in 2014

    • Figure North America Gabapentin Consumption Share by Types in 2018

    • Figure North America Gabapentin Consumption Share by Types in 2026

    • Table North America Gabapentin Consumption by End-Users from 2014 to 2026

    • Table North America Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Figure North America Gabapentin Consumption Share by End-Users in 2014

    • Figure North America Gabapentin Consumption Share by End-Users in 2018

    • Figure North America Gabapentin Consumption Share by End-Users in 2026

    • Table North America Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table North America Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Gabapentin Consumption Share by Major Countries in 2014

    • Figure North America Gabapentin Consumption Share by Major Countries in 2018

    • Figure North America Gabapentin Consumption Share by Major Countries in 2026

    • Figure United States Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Gabapentin Consumption by Types from 2014 to 2026

    • Table Europe Gabapentin Consumption Share by Types from 2014 to 2026

    • Figure Europe Gabapentin Consumption Share by Types in 2014

    • Figure Europe Gabapentin Consumption Share by Types in 2018

    • Figure Europe Gabapentin Consumption Share by Types in 2026

    • Table Europe Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Europe Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Gabapentin Consumption Share by End-Users in 2014

    • Figure Europe Gabapentin Consumption Share by End-Users in 2018

    • Figure Europe Gabapentin Consumption Share by End-Users in 2026

    • Table Europe Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table Europe Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Gabapentin Consumption Share by Major Countries in 2014

    • Figure Europe Gabapentin Consumption Share by Major Countries in 2018

    • Figure Europe Gabapentin Consumption Share by Major Countries in 2026

    • Figure Germany Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure France Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Gabapentin Consumption by Types from 2014 to 2026

    • Table Asia Pacific Gabapentin Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Gabapentin Consumption Share by Types in 2014

    • Figure Asia Pacific Gabapentin Consumption Share by Types in 2018

    • Figure Asia Pacific Gabapentin Consumption Share by Types in 2026

    • Table Asia Pacific Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Gabapentin Consumption Share by End-Users in 2014

    • Figure Asia Pacific Gabapentin Consumption Share by End-Users in 2018

    • Figure Asia Pacific Gabapentin Consumption Share by End-Users in 2026

    • Table Asia Pacific Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Gabapentin Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Gabapentin Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Gabapentin Consumption Share by Major Countries in 2026

    • Figure China Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandGabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure India Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Gabapentin Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Gabapentin Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Gabapentin Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Gabapentin Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Gabapentin Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Gabapentin Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Gabapentin Consumption Share by Major Countries in 2026

    • Figure GCC Countries Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Gabapentin Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Marksans Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marksans Pharma

    • Figure Sales and Growth Rate Analysis of Marksans Pharma

    • Figure Revenue and Market Share Analysis of Marksans Pharma

    • Table Product and Service Introduction of Marksans Pharma

    • Table Company Profile and Development Status of Alkem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkem

    • Figure Sales and Growth Rate Analysis of Alkem

    • Figure Revenue and Market Share Analysis of Alkem

    • Table Product and Service Introduction of Alkem

    • Table Company Profile and Development Status of Jiangsu Hengrui

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Hengrui

    • Figure Sales and Growth Rate Analysis of Jiangsu Hengrui

    • Figure Revenue and Market Share Analysis of Jiangsu Hengrui

    • Table Product and Service Introduction of Jiangsu Hengrui

    • Table Company Profile and Development Status of Sun Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

    • Table Product and Service Introduction of Sun Pharmaceutical

    • Table Company Profile and Development Status of Sailike

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sailike

    • Figure Sales and Growth Rate Analysis of Sailike

    • Figure Revenue and Market Share Analysis of Sailike

    • Table Product and Service Introduction of Sailike

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Jiangsu Enhua

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Enhua

    • Figure Sales and Growth Rate Analysis of Jiangsu Enhua

    • Figure Revenue and Market Share Analysis of Jiangsu Enhua

    • Table Product and Service Introduction of Jiangsu Enhua

    • Table Company Profile and Development Status of Arbor Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbor Pharma

    • Figure Sales and Growth Rate Analysis of Arbor Pharma

    • Figure Revenue and Market Share Analysis of Arbor Pharma

    • Table Product and Service Introduction of Arbor Pharma

    • Table Company Profile and Development Status of Assertio Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Assertio Therapeutics

    • Figure Sales and Growth Rate Analysis of Assertio Therapeutics

    • Figure Revenue and Market Share Analysis of Assertio Therapeutics

    • Table Product and Service Introduction of Assertio Therapeutics

    • Table Company Profile and Development Status of Apotex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex

    • Figure Sales and Growth Rate Analysis of Apotex

    • Figure Revenue and Market Share Analysis of Apotex

    • Table Product and Service Introduction of Apotex

    • Table Company Profile and Development Status of Aurobindo Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma

    • Figure Sales and Growth Rate Analysis of Aurobindo Pharma

    • Figure Revenue and Market Share Analysis of Aurobindo Pharma

    • Table Product and Service Introduction of Aurobindo Pharma

    • Table Company Profile and Development Status of Glenmark

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark

    • Figure Sales and Growth Rate Analysis of Glenmark

    • Figure Revenue and Market Share Analysis of Glenmark

    • Table Product and Service Introduction of Glenmark

    • Table Company Profile and Development Status of Intas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas

    • Figure Sales and Growth Rate Analysis of Intas

    • Figure Revenue and Market Share Analysis of Intas

    • Table Product and Service Introduction of Intas

    • Table Company Profile and Development Status of Amneal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amneal

    • Figure Sales and Growth Rate Analysis of Amneal

    • Figure Revenue and Market Share Analysis of Amneal

    • Table Product and Service Introduction of Amneal

    • Table Company Profile and Development Status of TEVA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TEVA

    • Figure Sales and Growth Rate Analysis of TEVA

    • Figure Revenue and Market Share Analysis of TEVA

    • Table Product and Service Introduction of TEVA


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US